ÔÚ¹ýÈ¥µÄ20ÄêÖУ¬ÖÎÁÆÐÔ¿¹ÌåÒѳÉΪÖÎÁƶñÐÔ¡¢¸ÐȾÐÔºÍ×ÔÉíÃâÒßÐÔ¼²²¡µÄÖØÒªÑ¡Ôñ¡£Æ¾½è¸ßÌØÒìÐÔ¡¢ÖÎÁƹ¦Ð§¡¢Îȶ¨ÐÔ¡¢ÈܽâÐÔ¡¢ÁÙ´²ÄÍÊÜÐÔºÍÏà¶Ô±ãÒ˵ÄÉú²ú³É±¾£¬µ¥¿Ë¡¿¹ÌåÔÚ°ÐÏòÖÎÁÆÁìÓòʵÏÖÁË·ÉÔ¾¡£
ÃâÒßÔÐÔ¼´ÉúÎïÖÆ¼ÁÓÕµ¼ÌåÒº»òϸ°û½éµ¼µÄÃâÒß·´Ó¦µÄÄÜÁ¦£¬³¤ÆÚÒÔÀ´Ò»Ö±ÊÇÖÎÁÆÐÔ¿¹ÌåµÄ¡°ÖÂÃüÈõµã¡±¡£ÖÎÁÆÊ±·ÇÈË¿¹Ìåͨ³£»á±»»¼ÕßµÄÃâÒßϵͳʶ±ðΪÍâÀ´¿¹Ì壬µ¼ÖÂÖÎÁÆÐÔ¿¹Ìå»òÆäÑÜÉúÎïµÄ¿ìËÙÇå³ý£¬ÏÞÖÆÁËÁÆÐ§¡£Ç¶ºÏ¿¹Ìåͨ¹ýʹÓÃÈË¿¹ºã¶¨ÇøÈ¡´úÊó¿¹ºã¶¨Çø£¬ÒÔ³¢ÊÔ½µµÍÃâÒßÔÐÔ¡£ÔÚCDRÒÆÖ²¿¹ÌåÖУ¬¿É±äÇøµÄÈËÔ´»¯³Ì¶È½øÒ»²½Ôö¼Ó£¬°ïÖúÃâÒßÔÐÔÌØÕ÷ÏÔÖø¸ÄÉÆ¡£È»¶øÈËÔ´»¯ÉõÖÁÍêÈ«ÈËÔ´¿¹ÌåÔÚ»¼ÕßÖлò¶à»òÉÙ¾ßÓÐÃâÒßÔÐÔµÄÎÊÌâÈÔÓдý½âÊÍ¡£
ÓëÌìÈ»ÈËÔ´¿¹ÌåÏà±È£¬´ó¶àÊýÈËÔ´»¯¿¹ÌåµÄCDRÇø±íÏÖ³ö²»Í¬µÄ½á¹¹ÕÛµþ×éºÏ£¬ÕâΪÓÕµ¼Õë¶ÔÖÎÁÆÐÔ¿¹ÌåµÄ²»Á¼ÃâÒßÓ¦´ðÌṩÁ˺ÏÀíµÄ½âÊÍ¡£ÕâЩ¹æ·¶½á¹¹£¨canonical structures£©±»Ö¤Ã÷¶ÔÓÚÔÚÈËÔ´»¯¿¹Ìåʱ±£³ÖÇ׺ÍÁ¦ÖÁ¹ØÖØÒª£¬Ò²¿ª±ÙÁ˳¬¼¶ÈËÔ´»¯µÄ·½·¨£¬¿ÉÒÔ½«Êó¿¹ÓëÈË¿¹¹æ·¶½á¹¹½øÐÐÆ¥Åä¡£»ùÓÚ¿¹ÌåµÄÁÆ·¨Í»ÆÆµÄÒ»¸öÖØÒªÇý¶¯Á¦ÊÇÈËÀà¡¢Äö³Ý¶¯ÎïºÍÆäËûÎïÖÖÖÖϵÃâÒßÇòµ°°×£¨Ig£©ÖØÁ´ºÍÇáÁ´£¨V£¬£¨D£©£¬JºÍC£©»ùÒòµÄ²âÐò/±íÕ÷¡£Ëü½ÒʾÁËIg¿âµÄ¹ã·º¶àÑùÐÔ£¬²¢½âÊÍÁËÆäʶ±ðºÍ½áºÏ¼¸ºõÈκξßÓв»Í¬Ç׺ÍÁ¦Ë®Æ½µÄ¿¹ÔµÄÄÜÁ¦¡£ÏÖÔÚÓÐÐí¶à²úÉúÈËÀàÖÎÁÆÐÔ¿¹ÌåµÄ¿¹Ìå·¢ÏÖÆ½Ì¨¿ÉÓ㬰üÀ¨×ª»ùÒòСÊóϵͳÒÔ¼°¿ÉÒÔͨ¹ý¸÷ÖÖչʾ¼¼ÊõɸѡµÄ·ÇÃâÒߺͺϳÉÈË¿¹Ìå¿â¡£
»ùÓÚÒÑ·¢±íµÄÃÀÖÞÍպ͵¥·åÍÕÌåÄÚ³ÉÊì³£¹æ¿¹ÌåµÄVHÇøÓò£¬Ñо¿ÈËÔ±×¢Òâµ½ÂæÍտƶ¯ÎïÓëÈËÀ࿹ÌåÐòÁи߶ȵÄͬԴÐÔ¡£¸ù¾ÝÈ«»ùÒò×éÄñǹÊý¾Ý¿â£¨WGS£©ºÍ¸ßͨÁ¿»ùÒò×é²âÐòÊý¾Ý¿â£¨HTG£©ÖÐÂæÍÕºÍÑòÍÕÊý¾Ý£¬¸÷×Ô¿ò¼ÜFR1¡¢FR2ºÍFR3µÄÒ»ÖÂÐÔ£¬CDR1ºÍCDR2µÄ³¤¶È£¬ÒÔ¼°¹æ·¶½á¹¹µÄÔ¤²â½á¹û±íÃ÷£¬ÂæÍտƶ¯ÎïºÍÈËÀ࿹ÌåV»ùÒò¿â¾ßÓÐÐòÁÐͬԴÐÔ¡£¹æ·¶½á¹¹Ô¤²â»ùÓÚChothia¹æ·¶£¬³ýÁËCDRµÄ³¤¶ÈÖ®Í⣬»¹¿¼ÂÇÁËCDRºÍFRsÖйؼü²Ð»ùµÄ´æÔÚ¡£´ËÍ⣬±È¶Ô±íÃ÷£¬ÔÚ²»Í¬µÄÂæÍÕÎïÖÖÖ®¼ä£¬IGHV¡¢IGLVºÍIGKV»ùÒòÊÇͬԴµÄ£¨ÓÐʱÉõÖÁÊÇÏàͬµÄ£©£¬²¢ÇÒ¹²ÏíÏàͬµÄVÇø¼Ò×åºÍÑǼÒ×å¡£
ÂæÍտƶ¯ÎïIGHV»ùÒò¿âÖ÷Òª°üÀ¨VH1¡¢VH3¡¢VHH3ºÍVH4»ùÒò¼Ò×å¡£³ýÁËIGHV1¡¢IGHV3¡¢IGHV4»ùÒò¼Ò×åÍ⣬»¹´æÔÚÊôÓÚIGHV5ºÍIGHV7»ùÒò¼Ò×å¡£ËùÓÐÎå¸öV»ùÒò¼Ò×å¶¼ÓëÈËÀà¶ÔÓ¦»ùÒò¼Ò×å¸ß¶ÈͬԴ¡£IGHV1»ùÓÚÆ¥ÅäµÄ¹æ·¶½á¹¹1-2£¨HCDR1ºÍHCDR2£©½øÐмø¶¨£¬ÕâЩ½á¹¹ÓëÈËÀàÖÖϵhIGHV1-1¡¢1-2¡¢1-3Ïà¹Ø¡£IGHV3¼Ò×åÈ·¶¨ÁË2¸öÑǼÒ×壬¿ÉÒÔ¸ù¾ÝÆäCDR2²Ð»ù×é³É½«Æäϸ·ÖΪ4×飨a-d£©¡£IGHV3Á½¸öÑǼÒ×å·Ö±ðÓë¾ßÓй淶½á¹¹1-3ºÍ1-1µÄhIGHV3-23ºÍIGHV3-66Ïà¹Ø¡£VHH3ÊÇÂæÍÕ¿ÆËùÌØÓе쬏ù¾Ý1-3ºÍ1-1µÄ¹æ·¶½á¹¹£¬¿É·ÖΪ2¸öÑǼÒ×壬һ¸öÑǼÒ×åÓëhIGHV3-30/hIGHV3-11Ïà¹Ø£¬Ò»¸öÑǼÒ×åÓëhIGHV3-66Ïà¹Ø¡£ÔÚIGHV4¼Ò×åÖУ¬¿ÉÒÔ¼ø¶¨³öÁ½¸öÑǼÒ×壺һ¸öÓëhIGHV4-30-4Ïà¹Ø£¬¹æ·¶½á¹¹Îª3-1£»ÁíÒ»¸öÓëhIGHV4-30-4¾ßÓÐÏàͬµÄHCDR1³¤¶È£¬µ«HCDR2²»Í¬£¬Õâ¿ÉÄܵ¼ÖÂÓëÈËÀàÅßϵIGHV4¶ÔÓ¦µÄ¹æ·¶ÕÛµþ²»Í¬¡£IGHV5ºÍIGHV7¼Ò×åÓëÈËÀàIGHV5-51ºÍIGHV7-4»ùÒò¾ßÓÐÏàͬµÄ¹æ·¶½á¹¹1-2¡£
ÂæÍտƶ¯ÎïIGHV1ºÍIGHV3ÓëÈËÀàIGHV¼Ò×åµÄFRÒ»ÖÂÐÔ92%~95%£¬IGHV4Ò»Ö¶ÈÖÁÉÙ82%¡£ÂæÍտƶ¯ÎïIGHV5ºÍIGHV7µÄFRÐòÁÐÒ»ÖÂÐԽϵͣ¬µ«ÈÔÓÐ77%¡£½øÒ»²½·ÖÎöÏÔʾ£¬VHH3ºÍVH3»ùÒò·Ö±ð°üº¬FR2µÄÇ×Ë®ÐÔ°±»ùËá²Ð»ùÌæ»»£¨F42/Y42, E49/Q49, R50/C50ºÍF52/G52/L52£©ºÍÊèË®ÐÔ°±»ùËáÌæ»»(V42/I42, G49, L50ºÍW52/S52)¡£
ͼ1 ÂæÍտƶ¯ÎïIGHV¿ò¼ÜÇøÓëÈË¿¹ÏàËÆ¶È±È¶Ô
ÂæÍտƶ¯ÎïIGLV1¼Ò×åÓÉ2¸öÓëhIGLV1-47ºÍhIGLV1-40Ïà¹ØµÄÑǼÒ×å×é³É£¬·Ö±ð°üº¬¹æ·¶½á¹¹13-7ºÍ14-7¡£·¢ÏֵĴó¶àÊýÂæÍտƶ¯ÎïIGLV2¼Ò×åÓëhIGLV2-18Óйأ¬¹æ·¶½á¹¹Îª14-7¡£IGLV3°üº¬Á½¸öÑǼÒ×壺һ¸öÓëhIGLV3-9¸üÏà¹Ø£¬¶øµÚ¶þ¸ö¿ÉÒÔ½øÒ»²½·ÖΪ3¸öÓëÈËÀàIGLV3-25Ïà¹Ø£¨Á½Õß¶¼¾ßÓй淶½á¹¹11-7£©¡£IGLV4¼Ò×å¿É·ÖΪ5¸öÑǼÒ×壬ÇÒ¾ùÓëhIGLV4-60×îÏàËÆ£¬¹æ·¶½á¹¹Îª14-11¡£IGLV5¼Ò×åÖÐ10¸öÑǼÒ×åÓëhIGLV5-39£¬hIGLV5-52£¬hIGLV5-37£¬hIGLV5-45Ò»ÖÂÐԽϸߣ¬ËùÓÐÑǼÒ×壨ÑǼÒ×å8³ýÍ⣩¹²ÏíÏàͬµÄ14-11¹æ·¶½á¹¹¡£IGLV6»ùÒòÓëhIGLV6-57ÏàËÆ£¬ÓÉÓÚ¹ýÔçÖÕÖ¹ÃÜÂë×Ó£¬ÎÞ·¨È·¶¨¹æ·¶½á¹¹¡£IGLV7»ùÒò½öÔÚÂæÍÕºÍÑòÍÕ»ùÒò×éÖмø¶¨³ö£¬²¢±»Ö¤Ã÷ÓëhIGLV7-46Ïà¹Ø£¬¹æ·¶½á¹¹Îª14-7¡£IGLV8ºÍIGLV9·Ö±ðÓÉ8¸öÑǼÒ×åºÍ2¸öÑǼÒ×å×é³É£¬·Ö±ðÓëhIGLV8-61ºÍhIGLV9-49Ïà¹Ø£¬¹æ·¶½á¹¹·Ö±ðΪ14-7ºÍ12-12¡£IGLV10¼Ò×åÓëhIGLV10-54Ïà¹Ø£¬¾ßÓÐÏàͬµÄ¹æ·¶½á¹¹13-7¡£
ÈýÖÖÖ÷ÒªµÄÈËÀàIGLV¼Ò×壨1-3£©ÓëÂæÍտƶ¯ÎïIGLV¸ß¶ÈͬԴ£¬»ùÓÚFRµÄÐòÁÐͬһÐÔÔÚ81%~91%¡£ÓÐȤµÄÊÇ£¬¾¡¹Ü×ÜÌåÒ»ÖÂÐÔÔÚ61%µ½91%Ö®¼ä£¬µ«ËùÓй淶½á¹¹¶¼ÓëÈËÀàVÇø¼Ò×åÏàÆ¥Åä¡£´ËÍ⣬¹Ø¼üλµã²Ð»ù±£Êز»½ö¾ÖÏÞÓÚ¿ò¼ÜÇø£¬¶øÇÒ»¹À©Õ¹µ½CDRÇø£¬ÂæÍÕºÍÈËÀàVÇø»ùÒòÖ®¼ä¿ò¼ÜÇøµÄÕâÖÖ¸ßÐòÁкͽṹÏàËÆÐÔÔÚÃâÒßÔÐÔ·½Ãæ¿ÉÄܷdz£ÖØÒª¡£
ͼ2 ÂæÍտƶ¯ÎïIGLV¿ò¼ÜÇøÓëÈË¿¹ÏàËÆ¶È±È¶Ô
ÂæÍÕ¿ÆIGKV¿âÓÉ6¸ö¼Ò×å×é³É£¬ÂæÍÕ¿ÆIGKV1¼Ò×åÓµÓÐÈý¸öÑǼÒ×壬ÓëhIGKV1-27ºÍhIGKV1-39Ïà¹Ø£¬²¢¾ßÓÐÏàͬµÄ¹æ·¶½á¹¹2-1¡£IGKV2¼Ò×åÓµÓÐÁ½¸öÑǼÒ×壬ÓëhIGKV2-29ºÍhIGKV2-40Ïà¹Ø£¬·Ö±ð¾ßÓй淶½á¹¹4-1ºÍ3-1¡£IGKV3ºÍIGKV4ÑǼÒ×å·Ö±ðÓëhIGKV3-11¡¢hIGKV4-1Ïà¹Ø£¬·Ö±ð¾ßÓй淶½á¹¹2-1ºÍ3-1¡£IGKV5ºÍIGKV6¼Ò×åÓëhIGKV5-1ºÍhIGKV6-41Ïà¹Ø£¬¾ù»ùÓÚ2-1¹æ·¶½á¹¹¡£
ÂæÍÕ¿ÆIGKV»ùÒòÓëÈËÀà»ùÒòµÄͬһÐÔ°Ù·Ö±ÈÔÚ60%ÖÁ85%Ö®¼ä£¬ÆäÖÐIGKV3»ùÒòµÄÏàËÆÐÔ×îµÍ¡£³ýÁËIGKV5£¬ÊóIGKV»ùÒòÓëÈËÀà»ùÒòµÄÇ×Ôµ¹ØÏµ¸üÃÜÇС£Í¬Ê±£¬Ò»ÖÂÐÔ²»½öÏÞÓÚ¿ò¼ÜÇø£¬CDRÇøÒ²ÊÇÈç´Ë¡£
ͼ3 ÂæÍտƶ¯ÎïIGKV¿ò¼ÜÇøÓëÈË¿¹ÏàËÆ¶È±È¶Ô
ΪÁ˽øÒ»²½Ö¤ÊµÂæÍտƶ¯ÎÌåºÍÈËÀ࿹ÌåVÇøÖ®¼ä½á¹¹Í¬Ô´ÐÔ£¬Ñо¿ÈËԱͨ¹ýXÉäÏß¾§Ìåѧȷ¶¨Á½ÖÖÂæÍÕ¿Æ¿¹ÌåµÄ½á¹¹¡£ÕâÁ½ÖÖ¿¹ÌåÊÇ´ÓʹÓÃÈËCD70»òMET¹ý±í´ïϸ°ûÖ÷¶¯ÃâÒßµÄÃÀÖÞÍÕÖÆ³ÉµÄÊɾúÌåչʾ¿¹Ìå¿âÖзÖÀëµÄ¡£CD70£¨Ò»ÖÖĤ½áºÏϸ°ûÒò×Ó£©ºÍMET£¨Ò»ÖÖÀÒ°±ËἤøÊÜÌ壩ÔÚÖ×ÁöÉú³¤/´æ»î¡¢Ñª¹ÜÉú³ÉºÍ×ªÒÆÖÐÆðÖØÒª×÷Óá£Í¨¹ý¶Ô»ñµÃµÄÃÀÖÞÍÕ¿¹ÌåXÉäÏß¾§Ìåѧ½øÐнṹ²â¶¨£¬¿¹CD70£¨PDB 4R90; VH3/V¦Ë7£©ºÍ¿¹MET£¨PDB 4R96; VH1/V¦Ê4£©¿¹Ìå½á¹¹·ÖÎö¼ûͼ4¡£
Èçͼ4CºÍ4D£¬ÃÀÖÞÍÕ¿¹MET£¨VH1/ V¦Ê4£©µ¥¿¹µÄ»·×´½á¹¹ÓëÈËÀàµÄÖØÁ´ºÍÇáÁ´£¨ÒÔPDB½á¹¹1FVDºÍ1HILΪģ°å£©ÏàËÆ¡£Ä£°å1FVD FabÖеÄHCDR1ºÍHCDR2µÄ¹æ·¶½á¹¹1-2Ó뿹MET Fab£¨ÊôÓÚIGHV1¼Ò×壩µÄ¹æ·¶½á¹¹·Ç³£ÎǺϣ¬ÕâÒâζ×ÅËüȷʵÀûÓÃÁËÓëÆ¥ÅäµÄÈËÀàÖÖϵVH1Ƭ¶ÎÏàͬµÄ¹æ·¶ÕÛµþ×éºÏ¡£´ËÍ⣬ÔÚ1HILÄ£°åÖУ¬LCDR1£¬LCDR2ºÍLCDR3£¨»ÒÉ«£©µÄ¹æ·¶½á¹¹3-1-1·Ö±ðÓ뿹MET¿¹ÌåµÄV¦ÊƬ¶Î£¨À¶É«£©ÍêÃÀÖØµþ¡£Õâ֤ʵÁËÃÀÖÞÍÕÑÜÉúµÄIGKV4ÓëÈËÀàIGKV4Ƭ¶ÎʹÓÃÏàͬµÄ¹æ·¶ÕÛµþ¡£×ÜÖ®£¬½á¹¹Êý¾ÝÃ÷È·µØÖ¤ÊµÁËÔÚÂæÍÕ¿ÆÀ´Ô´¿¹ÌåµÄ¿É±äÇøÓòÖдæÔÚµÄÈËÀ࿹ÌåµÄ¹æ·¶ÕÛµþ¡£
ͼ4 ÃÀÖÞÍÕÖØÁ´ºÍÇáÁ´VÓòºÍ¶ÔÓ¦ÈË¿¹µÄ¾§Ìå½á¹¹
(A)ÃÀÖÞÍÕ¿¹CD70¿¹Ìå VH£¨»ÆÉ«ºËÐÄ£¬ºìÉ«H1ºÍH2£¬³ÈÉ«CDR3)ÓëÈË¿¹£¨1MFA£¬»ÒÉ«£©µþ¼ÓЧ¹ûͼ
(B)ÃÀÖÞÍÕ¿¹CD70¿¹Ìå VL£¨·ÛÉ«ºËÐÄ£¬ÂÌÉ«H1-H3)ÓëÈË¿¹£¨»ÒÉ«£©µþ¼ÓЧ¹ûͼ
(C)ÃÀÖÞÍÕ¿¹MET¿¹Ìå VH£¨ÂÌÉ«ºËÐÄ£¬À¶É«H1-H2£¬ºìÉ«CDR3)ÓëÈËÖØÁ´²Î¿¼Îï1FVD£¨V¦Ê1£©ºÍ1HIL£¨V¦Ê4£©£¨»ÒÉ«)µþ¼ÓЧ¹ûͼ
(D)ÃÀÖÞÍÕ¿¹MET¿¹Ìå VK£¨ÂÌÉ«ºËÐÄ£¬À¶É«H1-H3£©ÓëÈËÖØÁ´²Î¿¼Îï1HIL£¨V¦Ê4£©£¨»ÒÉ«£©µþ¼ÓЧ¹ûͼ
²Î¿¼ÎÄÏ×
Alex Klarenbeek, Khalil El Mazouari, Aline Desmyter, et al(2015) Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform, mAbs, 7:4, 693-706, DOI: 10.1080/19420862.2015.1046648